+
Site Tour

EuroPCR 2023: Improving outcomes in mitral regurgitation

Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.

Related Videos

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: Defining the future

EuroPCR 2023: Vascular access

TAVI Summit - Cardiac imaging and morphology

Navitor™ Voice of the Experts Lars Sondergaard

TriClip™ G4: Animation

TAVI Summit - Cardiac imaging

AV VALVES 2023:Decision Making in HF–Tricuspid

TAVI Summit 2023: Aortic stenosis

AV VALVES 2023: MR – MAC

Navitor™: Voice of the Experts Nicolas Dumonteil

TRENDING TOPICS

TAVI Webinar Series | April

Key learnings for advanced TAVI

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

Epic Mitral – 10-Year Clinical Outcomes

Data Summary PFO closure in patients > 60 Years

PCR LV 2021: Navitor™ 30-day outcomes

ESOC presentation: PFO closure in patients > 60 Years

CONNEXT


LIVE
RELATED EVENTS

Screening Transmission | Mitral focus

Now you've got Navitor.
Future ready.

AV VALVES 2023: HoloLens Technology

AV VALVES 2023:HF and VHD – Patient Management

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline